An American company has developed a complete, comprehensive solution for somatic variant detection in cancer. The system includes a complete set of reagents to enable the wet laboratory chemistry, coupled with a comprehensive data analysis to produce detailed analysis and reports.

Using the system, scientists have everything at their fingertips to identify significant alterations from precious tumor FFPE samples using less material while producing the highest quality data.

Currently over 50 labs are performing somatic cancer tests in the US, 1,400 hospital cancer centers and 1,000 private oncology labs.